0
Editorial |

HMGA1, A Novel Locus for Type 2 Diabetes Mellitus

Abhimanyu Garg, MD
JAMA. 2011;305(9):938-939. doi:10.1001/jama.2011.236.
Text Size: A A A
Published online

Extract

Both genetic and environmental factors contribute to the pathogenesis of type 2 diabetes mellitus (DM). Linkage analysis and genome-wide association studies have revealed 34 common variants (also called single-nucleotide polymorphisms) associated with type 2 DM.1 Most of the loci are associated with either abnormal insulin processing or secretion, suggesting that most of the risk of type 2 DM in the population is due to beta cell dysfunction. However, some type 2 DM loci, such as peroxisome proliferator-activated receptor gamma (PPARG) and Kruppel-like factor 14 (KLF14), indicate defective insulin action or insulin resistance as a contributor.1 In addition, some genes (eg, glucokinase [hexokinase 4] regulator, insulin-like growth factor 1 [IGF1 ], and the fat mass and obesity associated gene) are associated with fasting insulin, insulin resistance, and obesity and may also contribute to type 2 DM.1 Most of the identified variants have modest effect sizes (1.1-1.3), and all of the type 2 DM–associated variants can explain only 10% to 15% of the heritability. Thus, there is a need to identify additional novel loci for type 2 DM. One approach is to conduct large-scale meta-analyses or association analyses with common variants.2 Another is to find rare variants in candidate genes selected for their known role in biological processes related to the disease.3,4

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario

brightcove.createExperiences();